142 related articles for article (PubMed ID: 27734393)
1. CCN2 in Skin Fibrosis.
Leask A
Methods Mol Biol; 2017; 1489():417-421. PubMed ID: 27734393
[TBL] [Abstract][Full Text] [Related]
2. CTGF/CCN2 exerts profibrotic action in myoblasts via the up-regulation of sphingosine kinase-1/S1P3 signaling axis: Implications in the action mechanism of TGFβ.
Bruno G; Cencetti F; Pertici I; Japtok L; Bernacchioni C; Donati C; Bruni P
Biochim Biophys Acta; 2015 Feb; 1851(2):194-202. PubMed ID: 25457224
[TBL] [Abstract][Full Text] [Related]
3. CCN2 is required for bleomycin-induced skin fibrosis in mice.
Liu S; Shi-wen X; Abraham DJ; Leask A
Arthritis Rheum; 2011 Jan; 63(1):239-46. PubMed ID: 20936632
[TBL] [Abstract][Full Text] [Related]
4. Studying the CCN Proteins in Fibrosis.
Hutchenreuther J; Leask A; Thompson K
Methods Mol Biol; 2017; 1489():423-429. PubMed ID: 27734394
[TBL] [Abstract][Full Text] [Related]
5. Denervation-induced skeletal muscle fibrosis is mediated by CTGF/CCN2 independently of TGF-β.
Rebolledo DL; González D; Faundez-Contreras J; Contreras O; Vio CP; Murphy-Ullrich JE; Lipson KE; Brandan E
Matrix Biol; 2019 Sep; 82():20-37. PubMed ID: 30716392
[TBL] [Abstract][Full Text] [Related]
6. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
7. CTGF/CCN2 is an autocrine regulator of cardiac fibrosis.
Dorn LE; Petrosino JM; Wright P; Accornero F
J Mol Cell Cardiol; 2018 Aug; 121():205-211. PubMed ID: 30040954
[TBL] [Abstract][Full Text] [Related]
8. Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation.
Rayego-Mateos S; Morgado-Pascual JL; Rodrigues-Diez RR; Rodrigues-Diez R; Falke LL; Mezzano S; Ortiz A; Egido J; Goldschmeding R; Ruiz-Ortega M
J Pathol; 2018 Feb; 244(2):227-241. PubMed ID: 29160908
[TBL] [Abstract][Full Text] [Related]
9. RNAi nanotherapy for fibrosis: highly durable knockdown of CTGF/CCN-2 using siRNA-DegradaBALL (LEM-S401) to treat skin fibrotic diseases.
Kang S; Kim J; Ahn M; Kim J; Heo MG; Min DH; Won C
Nanoscale; 2020 Mar; 12(11):6385-6393. PubMed ID: 32134425
[TBL] [Abstract][Full Text] [Related]
10. Loss of PTEN expression by mouse fibroblasts results in lung fibrosis through a CCN2-dependent mechanism.
Parapuram SK; Thompson K; Tsang M; Hutchenreuther J; Bekking C; Liu S; Leask A
Matrix Biol; 2015 Apr; 43():35-41. PubMed ID: 25644104
[TBL] [Abstract][Full Text] [Related]
11. SMAD3 and SP1/SP3 Transcription Factors Collaborate to Regulate Connective Tissue Growth Factor Gene Expression in Myoblasts in Response to Transforming Growth Factor β.
Córdova G; Rochard A; Riquelme-Guzmán C; Cofré C; Scherman D; Bigey P; Brandan E
J Cell Biochem; 2015 Sep; 116(9):1880-7. PubMed ID: 25727481
[TBL] [Abstract][Full Text] [Related]
12. Fibrosis caused by loss of PTEN expression in mouse fibroblasts is crucially dependent on CCN2.
Liu S; Parapuram SK; Leask A
Arthritis Rheum; 2013 Nov; 65(11):2940-4. PubMed ID: 23983074
[TBL] [Abstract][Full Text] [Related]
13. N-terminal domains of CCN family 2/connective tissue growth factor bind to aggrecan.
Aoyama E; Hattori T; Hoshijima M; Araki D; Nishida T; Kubota S; Takigawa M
Biochem J; 2009 May; 420(3):413-20. PubMed ID: 19298220
[TBL] [Abstract][Full Text] [Related]
14. Nicotine-induced CCN2: from smoking to periodontal fibrosis.
Takeuchi H; Kubota S; Murakashi E; Zhou Y; Endo K; Ng PS; Takigawa M; Numabe Y
J Dent Res; 2010 Jan; 89(1):34-9. PubMed ID: 19966042
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor-(CTGF, CCN2)--a marker, mediator and therapeutic target for renal fibrosis.
Phanish MK; Winn SK; Dockrell ME
Nephron Exp Nephrol; 2010; 114(3):e83-92. PubMed ID: 19955828
[TBL] [Abstract][Full Text] [Related]
16. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
Chujo S; Shirasaki F; Kawara S; Inagaki Y; Kinbara T; Inaoki M; Takigawa M; Takehara K
J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
[TBL] [Abstract][Full Text] [Related]
17. Activin A-Smad Signaling Mediates Connective Tissue Growth Factor Synthesis in Liver Progenitor Cells.
Ding ZY; Jin GN; Wang W; Sun YM; Chen WX; Chen L; Liang HF; Datta PK; Zhang MZ; Zhang B; Chen XP
Int J Mol Sci; 2016 Mar; 17(3):408. PubMed ID: 27011166
[TBL] [Abstract][Full Text] [Related]
18. CTGF/CCN2 from Skeletal Muscle to Nervous System: Impact on Neurodegenerative Diseases.
Gonzalez D; Brandan E
Mol Neurobiol; 2019 Aug; 56(8):5911-5916. PubMed ID: 30689195
[TBL] [Abstract][Full Text] [Related]
19. Fell-Muir lecture: Connective tissue growth factor (CCN2) -- a pernicious and pleiotropic player in the development of kidney fibrosis.
Mason RM
Int J Exp Pathol; 2013 Feb; 94(1):1-16. PubMed ID: 23110747
[TBL] [Abstract][Full Text] [Related]
20. CCN5 attenuates profibrotic phenotypes of fibroblasts through the Smad6-CCN2 pathway: Potential role in epidural fibrosis.
Xu H; Liu C; Sun Z; Guo X; Zhang Y; Liu M; Li P
Int J Mol Med; 2015 Jul; 36(1):123-9. PubMed ID: 25901787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
